FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048701510> ?p ?o ?g. }

• W2048701510 endingPage "1775" @default.
• W2048701510 startingPage "1769" @default.
• W2048701510 abstract "The major purpose of the present study was to determine the effect of the potassium channel opener bimakalim, administered intracoronary only during the initial 10 minutes of ischemia, on myocardial infarct size in anesthetized dogs. A second aim was to test the possibility that bimakalim mediates its cardioprotective effects by accelerating the rate of myocyte action potential shortening during early ischemia. A third aim was to determine the relative potency of bimakalim to open coronary vascular ATP-regulated potassium (KATP) channels versus myocyte KATP channels.Barbital-anesthetized open-chest dogs were used. In the initial studies, bimakalim (0.1 to 10 micrograms/min) was infused into the left anterior descending coronary artery (LAD), and changes in coronary blood flow and monophasic action potential duration (MAPD) were used as indexes of coronary vascular KATP channel and myocyte KATP channel activity, respectively. In subsequent infarct studies, dogs were subjected to 60 minutes of LAD occlusion followed by 4 hours of reperfusion. Based on preliminary studies, two doses of bimakalim that did not shorten MAPD during nonischemic conditions (0.1 and 0.3 microgram/min) and one that markedly shortened MAPD during nonischemic conditions (3.0 micrograms/min) or an equal volume of vehicle were infused into the LAD during the initial 10 minutes of coronary artery occlusion. Transmural myocardial blood flow was measured at 5 and 30 minutes of occlusion by the radioactive microsphere technique, and infarct size was determined at the end of 4 hours of reperfusion by triphenyltetrazolium staining. The monophasic action potential duration at 50% repolarization (MAPD50) was measured by an epicardial probe placed in the center of the ischemic area. Bimakalim had an approximately 10-fold greater affinity for the coronary vascular than the myocardial KATP channel (ED50 coronary, approximately 0.3 microgram/min; ED50 myocyte, approximately 3.0 micrograms/min). Three doses of bimakalim (0.1, 0.3, and 3.0 micrograms/min) all markedly reduced infarct size expressed as percent of the area at risk (12.6 +/- 3.3%, 14.5 +/- 2.2%, and 14.2 +/- 5.3%, respectively, versus 27.2 +/- 5.7% in controls) to nearly equal extents. Subsequently, we found that the two higher doses of bimakalim (0.3 and 3.0 micrograms/min) markedly accelerated yet the 0.1-microgram/min dose of bimakalim did not significantly affect the ischemia-related shortening of the action potential during the initial 5 minutes of occlusion. In addition, 0.1 and 0.3 microgram/min bimakalim did not increase the incidence of ventricular fibrillation during the 60 minutes of occlusion (0 of 7 and 0 of 8 dogs, respectively), whereas 3.0 micrograms/min bimakalim had a profibrillatory effect (6 of 6) compared with the control group (1 of 8). There were no significant differences between groups in systemic hemodynamics, myocardial oxygen demand, ischemic bed size, or collateral blood flow to the ischemic region.The results of the present study clearly reveal that a small dose (0.1 or 0.3 microgram/min) of the KATP channel opener bimakalim administered only during the initial 10-minute period of ischemia markedly reduced myocardial infarct size to an extent equal to that of a higher profibrillatory dose in barbital-anesthetized dogs. These data also suggest that bimakalim and other potassium channel openers may partially exert their cardioprotective effects by accelerating KATP channel activation during early ischemia as evidenced by an enhanced rate of ischemic myocyte action potential shortening. However, the results also suggest that other cellular mechanisms may be involved in mediating the cardioprotection produced by a low dose of bimakalim (0.1 microgram/min) because it did not significantly accelerate the shortening of the action potential duration, yet it had an efficacy to reduThe major purpose of the present study was to de" @default.
• W2048701510 created "2016-06-24" @default.
• W2048701510 creator A5030692703 @default.
• W2048701510 creator A5043653346 @default.
• W2048701510 date "1994-04-01" @default.
• W2048701510 modified "2023-10-17" @default.
• W2048701510 title "Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs." @default.
• W2048701510 cites W1972005652 @default.
• W2048701510 cites W1975450543 @default.
• W2048701510 cites W1977622881 @default.
• W2048701510 cites W1979445849 @default.
• W2048701510 cites W1985336069 @default.
• W2048701510 cites W1987946315 @default.
• W2048701510 cites W1988224186 @default.
• W2048701510 cites W1999254539 @default.
• W2048701510 cites W2008240984 @default.
• W2048701510 cites W2038077272 @default.
• W2048701510 cites W2052410115 @default.
• W2048701510 cites W2054220851 @default.
• W2048701510 cites W2058324141 @default.
• W2048701510 cites W2061238309 @default.
• W2048701510 cites W2064953660 @default.
• W2048701510 cites W2082280658 @default.
• W2048701510 cites W2116275405 @default.
• W2048701510 cites W2159191190 @default.
• W2048701510 cites W2403482739 @default.
• W2048701510 doi "https://doi.org/10.1161/01.cir.89.4.1769" @default.
• W2048701510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8149542" @default.
• W2048701510 hasPublicationYear "1994" @default.
• W2048701510 type Work @default.
• W2048701510 sameAs 2048701510 @default.
• W2048701510 citedByCount "241" @default.
• W2048701510 countsByYear W20487015102012 @default.
• W2048701510 countsByYear W20487015102013 @default.
• W2048701510 countsByYear W20487015102014 @default.
• W2048701510 countsByYear W20487015102015 @default.
• W2048701510 countsByYear W20487015102016 @default.
• W2048701510 countsByYear W20487015102019 @default.
• W2048701510 countsByYear W20487015102020 @default.
• W2048701510 countsByYear W20487015102022 @default.
• W2048701510 countsByYear W20487015102023 @default.
• W2048701510 crossrefType "journal-article" @default.
• W2048701510 hasAuthorship W2048701510A5030692703 @default.
• W2048701510 hasAuthorship W2048701510A5043653346 @default.
• W2048701510 hasBestOaLocation W20487015101 @default.
• W2048701510 hasConcept C126322002 @default.
• W2048701510 hasConcept C158846371 @default.
• W2048701510 hasConcept C164705383 @default.
• W2048701510 hasConcept C2776820930 @default.
• W2048701510 hasConcept C2776894844 @default.
• W2048701510 hasConcept C2780393670 @default.
• W2048701510 hasConcept C42219234 @default.
• W2048701510 hasConcept C500558357 @default.
• W2048701510 hasConcept C541997718 @default.
• W2048701510 hasConcept C71924100 @default.
• W2048701510 hasConcept C83743174 @default.
• W2048701510 hasConceptScore W2048701510C126322002 @default.
• W2048701510 hasConceptScore W2048701510C158846371 @default.
• W2048701510 hasConceptScore W2048701510C164705383 @default.
• W2048701510 hasConceptScore W2048701510C2776820930 @default.
• W2048701510 hasConceptScore W2048701510C2776894844 @default.
• W2048701510 hasConceptScore W2048701510C2780393670 @default.
• W2048701510 hasConceptScore W2048701510C42219234 @default.
• W2048701510 hasConceptScore W2048701510C500558357 @default.
• W2048701510 hasConceptScore W2048701510C541997718 @default.
• W2048701510 hasConceptScore W2048701510C71924100 @default.
• W2048701510 hasConceptScore W2048701510C83743174 @default.
• W2048701510 hasIssue "4" @default.
• W2048701510 hasLocation W20487015101 @default.
• W2048701510 hasLocation W20487015102 @default.
• W2048701510 hasOpenAccess W2048701510 @default.
• W2048701510 hasPrimaryLocation W20487015101 @default.
• W2048701510 hasRelatedWork W1991861873 @default.
• W2048701510 hasRelatedWork W2035928331 @default.
• W2048701510 hasRelatedWork W2040748468 @default.
• W2048701510 hasRelatedWork W2091343426 @default.
• W2048701510 hasRelatedWork W2095734514 @default.
• W2048701510 hasRelatedWork W2154954671 @default.
• W2048701510 hasRelatedWork W2369941816 @default.
• W2048701510 hasRelatedWork W2969855425 @default.
• W2048701510 hasRelatedWork W3141787527 @default.
• W2048701510 hasRelatedWork W2493920666 @default.
• W2048701510 hasVolume "89" @default.
• W2048701510 isParatext "false" @default.
• W2048701510 isRetracted "false" @default.
• W2048701510 magId "2048701510" @default.
• W2048701510 workType "article" @default.